ImaRx Reschedules Release of Corporate Updates and Fourth Quarter and Full Year 2007 Financi...( Live Webcast and Conference Call Sch...)
| HOME >> BIOLOGY >> TECHNOLOGY |
Live Webcast and Conference Call Scheduled for Monday, March 31st at 5 PM
ET
TUCSON, Ariz., March 26 /PRNewswire-FirstCall/ -- ImaRx Therapeutics, Inc. (Nasdaq: IMRX) today announced that the Company has rescheduled a live webcast and conference call, which will now take place on Monday, March 31, 2008, at 5:00 p.m. ET to discuss corporate updates and financial results for the fourth quarter and full year 2007.
The live webcast can be accessed through ImaRx's corporate website at http://www.imarx.com and will be archived on the website for 14 days following the event.
Interested parties may access the conference call by dialing (877) 407- 4018 in the U.S. and Canada or (201) 689-8471 internationally. A telephonic replay will be available through April 8, 2008 by dialing (877) 660-6853 in the U.S. and Canada or (201) 612-7415 internationally (Account Number 3055 and Conference ID 279436).
About ImaRx Therapeutics
ImaRx Therapeutics is a biopharmaceutical company commercializing and
developing therapies for vascular disorders. The Company's
commercialization efforts are currently focused on its FDA approved
product, urokinase, for the treatment of acute massive pulmonary embolism.
The Company's research and development efforts are focused on therapies for
stroke and other vascular disorders using its proprietary microbubble
technology.
Contacts:
The Ruth Group (Investors/Media)
Sara Ephraim/Jason Rando
646-536-7002 or 7025
'/>"/>
| SOURCE ImaRx Therapeutics, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
2. ImaRx to Report Corporate Updates and 4Q07 Financial Results
3. New Edition of Definitive Resource in Tissue Engineering Released Today
4. Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
5. Instant JChem 2.0 Released: Instant JChem Personal Free for All Users
6. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
7. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
8. Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System
9. WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007
10. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
11. Dynatronics to Release Fourth Quarter and Year-end Results Friday, September 14, 2007; Conference Call set for 1:00 p.m. ET
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |